CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $85,328,124
- in 21 filings, $85.3M under 10b5-1 plans
Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-26 | Cislini Jeff General Counsel | Sale 10b5-1 | −2,000 | $38.47 | $77K | 49,487 |
| 2024-06-25 | Kelsey Stephen Michael See Remarks | Option exercise 10b5-1 | +16,467 | $4.09 | $67K | 285,540 |
| 2024-06-25 | Kelsey Stephen Michael See Remarks | Sale 10b5-1 | −16,467 | $39.06 | $643K | 269,073 |
| 2024-06-25 | Kelsey Stephen Michael See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −16,467 | 89,999 | ||
| 2024-06-24 | Kelsey Stephen Michael See Remarks | Option exercise 10b5-1 | +200 | $4.09 | $818 | 269,273 |
| 2024-06-24 | Kelsey Stephen Michael See Remarks | Sale 10b5-1 | −200 | $39.00 | $8K | 269,073 |
| 2024-06-24 | Kelsey Stephen Michael See Remarks | Option exercise · Stock Option (Right to Buy) 10b5-1 | −200 | 106,466 | ||
| 2024-06-20 | ANDERSON ELIZABETH M Director | Grant or award | +4,248 | 20,073 | ||
| 2024-06-20 | ANDERSON ELIZABETH M Director | Grant or award · Stock Option (Right to Buy) | +15,955 | 15,955 | ||
| 2024-06-20 | Borellini Flavia Director | Grant or award | +4,248 | 21,882 | ||
| 2024-06-20 | Borellini Flavia Director | Grant or award · Stock Option (Right to Buy) | +15,955 | 15,955 | ||
| 2024-06-20 | Weber Barbara Director | Grant or award | +4,248 | 20,073 | ||
| 2024-06-20 | Weber Barbara Director | Grant or award · Stock Option (Right to Buy) | +15,955 | 15,955 | ||
| 2024-06-20 | Kim Lorence H. Director | Grant or award | +4,248 | 69,948 | ||
| 2024-06-20 | Kim Lorence H. Director | Grant or award · Stock Option (Right to Buy) | +15,955 | 15,955 | ||
| 2024-06-20 | Borisy Alexis Director | Grant or award | +4,248 | 2,335,742 | ||
| 2024-06-20 | Borisy Alexis Director | Grant or award · Stock Option (Right to Buy) | +15,955 | 15,955 | ||
| 2024-06-20 | Patel Sushil Director | Grant or award | +4,248 | 19,948 | ||
| 2024-06-20 | Patel Sushil Director | Grant or award · Stock Option (Right to Buy) | +15,955 | 15,955 | ||
| 2024-06-20 | Horning Sandra Director | Grant or award | +2,945 | 93,432 |
Page 24 of 29 · 569 trades